Kate Khair, RN, PhD

Director of Research
Haemnet, London, United Kingdom
London, England, United Kingdom

Dr. Khair RN, RSCN, PhD is s the Director of Research at Haemnet, London, UK. She is an advocate of the nurse’s role in the multidisciplinary team and is widely recognized for her contributions in hemophilia. Her recent focus is on outcomes research in bleeding disorders. She is the editor in chief of The Journal of Haemophilia Practice. In 2021, Dr. Khair was made Honorary Vice President of the UK Haemophilia Society in recognition of her years as a volunteer and Trustee.

Presentation(s):

• PB0228 - A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: A First Report

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0632 - Quality of life outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0636 - Clinical outcomes following treatment with octocog alfa in patients with severe hemophilia A and pre-existing target joints: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0666 - Clinical outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• OC 52.4 - The impact of steroids following gene therapy for haemophilia: results from the Exigency study

  Tuesday, June 27, 2023
  11:30 – 11:45 ET

• PB1375 - Menstrual bleeding in women with Glanzmanns Thombasthenia - Results from the Glanzmanns 360 Study (GT360)

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1377 - Living with Glanzmann’s Thrombasthenia: An interim report from the Glanzmann’s 360 international patient survey

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1393 - Living with Glanzmann’s Thrombasthenia: An interim report on 14 qualitative interviews from the Glanzmann’s 360 Study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET